Does FEDRATINIB Cause Product dose omission issue? 34 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Product dose omission issue have been filed in association with FEDRATINIB (Inrebic). This represents 2.4% of all adverse event reports for FEDRATINIB.
34
Reports of Product dose omission issue with FEDRATINIB
2.4%
of all FEDRATINIB reports
0
Deaths
4
Hospitalizations
How Dangerous Is Product dose omission issue From FEDRATINIB?
Of the 34 reports, 4 (11.8%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FEDRATINIB. However, 34 reports have been filed with the FAERS database.
What Other Side Effects Does FEDRATINIB Cause?
Diarrhoea (143)
Death (138)
Nausea (114)
Fatigue (105)
Vomiting (74)
Constipation (59)
Platelet count decreased (48)
Asthenia (47)
Haemoglobin decreased (46)
Full blood count decreased (45)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which FEDRATINIB Alternatives Have Lower Product dose omission issue Risk?
FEDRATINIB vs FELBAMATE
FEDRATINIB vs FELIS CATUS HAIR
FEDRATINIB vs FELODIPINE
FEDRATINIB vs FENFLURAMINE
FEDRATINIB vs FENOFIBRATE